Report Detail
Global Cardiac Biomarkers Testing Market Growth (Status and Outlook) 2019-2024
- RnM3574906 |
- 05 July, 2019 |
- Global |
- 116 Pages |
- LPI(LP Information) |
- Other
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
According to this study, over the next five years the Cardiac Biomarkers Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cardiac Biomarkers Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cardiac Biomarkers Testing market by product type, application, key companies and key regions.
This study considers the Cardiac Biomarkers Testing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. HOFFMANN-LA ROCHE LTD.
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cardiac Biomarkers Testing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cardiac Biomarkers Testing market by identifying its various subsegments.
Focuses on the key global Cardiac Biomarkers Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cardiac Biomarkers Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cardiac Biomarkers Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cardiac Biomarkers Testing Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cardiac Biomarkers Testing Market Size 2014-2024
- 2.1.2 Cardiac Biomarkers Testing Market Size CAGR by Region
- 2.2 Cardiac Biomarkers Testing Segment by Type
- 2.2.1 Myocardial Muscle Creatine Kinase (CK-MB)
- 2.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
- 2.2.3 Myoglobin
- 2.2.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
- 2.2.5 Ischemia-modified Albumin (IMA)
- 2.2.6 Others
- 2.3 Cardiac Biomarkers Testing Market Size by Type
- 2.3.1 Global Cardiac Biomarkers Testing Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (2014-2019)
- 2.4 Cardiac Biomarkers Testing Segment by Application
- 2.4.1 Myocardial Infarction
- 2.4.2 Congestive Heart Failure
- 2.4.3 Acute Coronary Syndrome
- 2.4.4 Atherosclerosis
- 2.4.5 Others
- 2.5 Cardiac Biomarkers Testing Market Size by Application
- 2.5.1 Global Cardiac Biomarkers Testing Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Cardiac Biomarkers Testing Market Size Growth Rate by Application (2014-2019)
3 Global Cardiac Biomarkers Testing by Players
- 3.1 Global Cardiac Biomarkers Testing Market Size Market Share by Players
- 3.1.1 Global Cardiac Biomarkers Testing Market Size by Players (2017-2019)
- 3.1.2 Global Cardiac Biomarkers Testing Market Size Market Share by Players (2017-2019)
- 3.2 Global Cardiac Biomarkers Testing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cardiac Biomarkers Testing by Regions
- 4.1 Cardiac Biomarkers Testing Market Size by Regions
- 4.2 Americas Cardiac Biomarkers Testing Market Size Growth
- 4.3 APAC Cardiac Biomarkers Testing Market Size Growth
- 4.4 Europe Cardiac Biomarkers Testing Market Size Growth
- 4.5 Middle East & Africa Cardiac Biomarkers Testing Market Size Growth
5 Americas
- 5.1 Americas Cardiac Biomarkers Testing Market Size by Countries
- 5.2 Americas Cardiac Biomarkers Testing Market Size by Type
- 5.3 Americas Cardiac Biomarkers Testing Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cardiac Biomarkers Testing Market Size by Countries
- 6.2 APAC Cardiac Biomarkers Testing Market Size by Type
- 6.3 APAC Cardiac Biomarkers Testing Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cardiac Biomarkers Testing by Countries
- 7.2 Europe Cardiac Biomarkers Testing Market Size by Type
- 7.3 Europe Cardiac Biomarkers Testing Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cardiac Biomarkers Testing by Countries
- 8.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type
- 8.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Cardiac Biomarkers Testing Market Forecast
- 10.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
- 10.2 Global Cardiac Biomarkers Testing Forecast by Regions
- 10.2.1 Global Cardiac Biomarkers Testing Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Cardiac Biomarkers Testing Forecast by Type
- 10.8 Global Cardiac Biomarkers Testing Forecast by Application
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Company Details
- 11.1.2 Cardiac Biomarkers Testing Product Offered
- 11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbott Laboratories News
- 11.2 Becton, Dickinson and Company
- 11.2.1 Company Details
- 11.2.2 Cardiac Biomarkers Testing Product Offered
- 11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Becton, Dickinson and Company News
- 11.3 BioMerieux
- 11.3.1 Company Details
- 11.3.2 Cardiac Biomarkers Testing Product Offered
- 11.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 BioMerieux News
- 11.4 Bio-Rad Laboratories, Inc.
- 11.4.1 Company Details
- 11.4.2 Cardiac Biomarkers Testing Product Offered
- 11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Bio-Rad Laboratories, Inc. News
- 11.5 Danaher Corporation
- 11.5.1 Company Details
- 11.5.2 Cardiac Biomarkers Testing Product Offered
- 11.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Danaher Corporation News
- 11.6 F. HOFFMANN-LA ROCHE LTD.
- 11.6.1 Company Details
- 11.6.2 Cardiac Biomarkers Testing Product Offered
- 11.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 F. HOFFMANN-LA ROCHE LTD. News
- 11.7 Siemens AG
- 11.7.1 Company Details
- 11.7.2 Cardiac Biomarkers Testing Product Offered
- 11.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Siemens AG News
- 11.8 Thermo Fisher Scientific, Inc.
- 11.8.1 Company Details
- 11.8.2 Cardiac Biomarkers Testing Product Offered
- 11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Thermo Fisher Scientific, Inc. News
- 11.9 PerkinElmer Inc.
- 11.9.1 Company Details
- 11.9.2 Cardiac Biomarkers Testing Product Offered
- 11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 PerkinElmer Inc. News
- 11.10 Tosoh Corporation
- 11.10.1 Company Details
- 11.10.2 Cardiac Biomarkers Testing Product Offered
- 11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Tosoh Corporation News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cardiac Biomarkers Testing. Industry analysis & Market Report on Cardiac Biomarkers Testing is a syndicated market report, published as Global Cardiac Biomarkers Testing Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Cardiac Biomarkers Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
